GEM-Based Metabolic Profiling for Human Bone Osteosarcoma under Different Glucose and Glutamine Availability

Area of Science:

• Metabolic Engineering
• Computational Biology
• Cancer Research

Background:

• Cancer cell metabolism is influenced by both genetics and nutrient availability.
• Understanding the interplay between these factors is crucial for developing personalized cancer treatments.
• Genome-scale metabolic models (GEMs) are valuable tools, but rarely integrate genetic and nutrient data simultaneously.

Purpose of the Study:

• To develop a novel framework, integrated metabolic profiling, for enhancing GEMs with gene expression and nutrient data.
• To enable a more comprehensive analysis of cancer cell metabolism by considering intrinsic and extrinsic factors together.
• To improve the accuracy and applicability of GEMs for personalized cancer therapy.

Main Methods:

• RNA sequencing (RNA-seq) data was converted into Reaction Activity Scores (RAS) to adjust metabolic reaction bounds.
• Nutrient availability information was translated into Maximal Uptake Rates (MUR) to modify GEM exchange reactions.
• The framework was applied to the human osteosarcoma cell line (U2OS) for validation.

Main Results:

• The integrated metabolic profiling framework successfully combined gene expression and nutrient data within GEMs.
• The study identified U2OS cells as a glutamine-dependent cancer type.
• The framework demonstrated the potential for more accurate metabolic modeling in cancer.

Conclusions:

• Integrated metabolic profiling offers a powerful approach to enrich GEMs with multi-omics data.
• This method advances the understanding of cancer metabolism and its regulation by diet.
• The framework holds promise for advancing personalized medicine in oncology, particularly for cancers like osteosarcoma.